Search
for
Sort by
Research 841–870 of 920
- Comprehensive HPLC and UPLC-MS/MS Analysis for the Multi-component Detection of Hair Growth Compounds in Consumer Health Products
- The Safety and Efficacy of a Novel Saw Palmetto ( <i>Serenoa repens</i> ) Extract for Promoting Hair Growth in Adults With Self‐Perceived Thinning Hair: 180‐Day Results
- Comparative evaluation of eyebrow rejuvenation using hibiscus oil 5% (w/v) with and without Gua-sha: A split face randomized control Trial
- Different Patterns of Lichen Planus in Three Members of One Family
- Pathophysiology of Androgenetic Alopecia and Implications for Treatment: An Overview of Current Literature
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Expert consensus on systemic treatment activation and grading evaluation for alopecia areata
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Ophthalmologic Comorbidities in Alopecia Areata
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience
- Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss
- Real-world evidence in alopecia areata treatment: A narrative review
- Quality of life in patients with scarring and non‐scarring alopecia: An exploratory cross‐sectional study
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
- Comorbidities in primary cicatricial alopecia: a systematic review and meta-analysis
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Frontal Fibrosing Alopecia and the Role of Cosmeceuticals in Its Pathogenesis
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Enhancing hair regrowth in Alopecia areata: the power duo of CO2 fractional laser and Bimatoprost
- Recent Advances in Drug Development for Hair Loss
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment